Best International Grants for Nonprofits

The Humanity United Grant focuses on addressing human exploitation and violent conflict through a strategic approach. It emphasizes support for registered charities and initiatives globally, particularly in regions like Asia-Pacific and South Sudan. The grant fosters collaboration among partners to promote human dignity, racial justice, and peacebuilding. Interested organizations are encouraged to align their proposals with the outlined themes and engage with the funder for potential support.

The Cytokinetics Communications Grant Program provides five grants of $20,000 each annually to patient advocacy organizations focused on hypertrophic cardiomyopathy (HCM) and heart failure. This initiative aims to enhance communication and outreach efforts, helping organizations expand their community engagement and awareness. By supporting crucial marketing initiatives, Cytokinetics fosters improved resources for advocacy groups, ensuring they can effectively address the needs of patients facing muscle performance challenges.

The F5 STEM Education and AI Grants for Women and Girls of Color aim to support nonprofit organizations that enhance access to STEM education and career opportunities for underrepresented groups. With a focus on women and girls of color, the grants provide $50,000 in unrestricted funding to organizations with a commitment to increasing representation in the tech sector. Applications from around the world are welcomed, with priority given to those emphasizing AI literacy and tool usage.

The Antarctic Research Not Requiring U.S. Antarctic Program (USAP) Field Support grant invites innovative proposals that do not necessitate USAP logistical support. It aims to enhance understanding of Antarctic and global systems, advance fundamental Earth science, and support diverse workforce development in polar-related science. The grant encourages interdisciplinary research, including studies using existing data or conducted outside Antarctica that relate to Antarctic systems, while explicitly excluding projects needing USAP support.

Pfizer is launching a grant initiative to enhance care for patients with advanced ALK+ non-small cell lung cancer (NSCLC). This program aims to support independent medical education projects focusing on patient and caregiver preparation for ALK inhibitor therapy, side-effect management, and the development of resources that promote informed decision-making and accessibility. By addressing the challenges faced by this patient population, the initiative seeks to improve treatment outcomes and quality of life.

The Thrive Grant supports initiatives aimed at establishing equitable, plant-based food systems by decreasing animal consumption and promoting vegan advocacy. Targeting mid-size to larger organizations with proven success, the grant encourages proposals that align with Thrive Philanthropy's mission. Eligible applicants should demonstrate a strong community reputation and are expected to operate outside the U.S. Notably, the grant excludes for-profit entities and projects that exploit animals.

The ECTRIMS Clinical Training Fellowship Programme offers neurologists and physicians a unique opportunity to enhance their expertise in multiple sclerosis (MS) management. With training periods of 3, 6, or 12 months under experienced mentors in European MS clinics, selected fellows receive stipends ranging from €13,750 to €55,000. This prestigious fellowship emphasizes cross-border collaboration and aims to foster the next generation of MS professionals, especially from less-developed countries where MS is prevalent.

The International Foundation Grant is aimed at U.S.-based non-profit organizations working in developing countries to enhance health, education, and income levels for impoverished communities. While currently not accepting new applications, the foundation reviews proposals from previously invited organizations. The focus lies on holistic, community-driven projects in sectors such as agriculture, education, environment, and health. Partnerships with local entities are encouraged to ensure sustainable and impactful outcomes.

The National MS Society offers Career Transition Fellowships for non-U.S. institutions to support the development of young scientists dedicated to MS research. This fellowship is aimed at postdoctoral trainees who have shown exceptional potential in their field. Recipients receive funding for two years of advanced training and three years of research support in a faculty position. Proposals must align with the Society's priority research areas, contributing to innovative solutions for those affected by MS.

The Joseph Rowntree Charitable Trust (JRCT) focuses on promoting human rights and justice for marginalized communities, particularly racial and religious minorities. It supports advocacy and campaigns that aim to hold authorities accountable and foster public understanding of these issues. In light of the Covid-19 pandemic, JRCT is particularly interested in funding projects that address the intertwined challenges of systemic racism and public health crises, encouraging innovative solutions that empower affected communities.

The U.S.-Africa Strategic Investment Program aims to enhance America's national interests by fostering private sector-led growth in sub-Saharan Africa. Focusing on Critical Minerals Investment and Commercial Diplomacy Acceleration, this initiative encourages market-based solutions that attract foreign investment. Projects must provide measurable benefits to sub-Saharan countries, promoting sustainable economic growth and increasing investment from high-quality U.S. and U.S.-aligned companies, while creating favorable conditions for U.S. commercial participation.

About Pfizer Grants

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders

There remains a scientific gap in understanding of the role of anti-TFPImediated hemostatic rebalancing in the context of inherited or non-hemophilic bleeding disorders. This competitive grant program encourages competitive submissions focsed on generating preclinical/foundational data exploring the therapeutic potential and mechanisms of TFPI modulation in bleeding disorders other than hemophilia.

Project Types and Area of Interest

Potential applicants are encouraged to identify and address preclinical/basic science data generation for TFPI modulation/rebalancing in their local setting. This may include:

• Rare bleeding disorders which arise from deficiencies in different clotting factors or pathway components but converge on a common functional endpoint which is an impaired thrombin generation (e.g., Factor II, Factor V, Factor VII, Factor X and Factor XI deficiencies, as well as von Willebrand disease).
• Other diseases such as Glanzmann's thrombasthenia (GT) that have a distinct pathophysiological mechanism.
• Other rare bleeding disorders whose mechanisms are not well understood (e.g., Bleeding Disorder of Unknown Cause, BDUC).